Cargando…
The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity
INTRODUCTION: One in three US adults is living with obesity or hypertension, and more than 75% of hypertensive individuals are using antihypertensive medications. Therefore, it is important to examine blood pressure (BP) differences in populations that are using these medications with differing obes...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188586/ https://www.ncbi.nlm.nih.gov/pubmed/30364090 http://dx.doi.org/10.1155/2018/4573258 |
_version_ | 1783363208946384896 |
---|---|
author | Parikh, Jash S. Randhawa, Arshdeep K. Wharton, Sean Edgell, Heather Kuk, Jennifer L. |
author_facet | Parikh, Jash S. Randhawa, Arshdeep K. Wharton, Sean Edgell, Heather Kuk, Jennifer L. |
author_sort | Parikh, Jash S. |
collection | PubMed |
description | INTRODUCTION: One in three US adults is living with obesity or hypertension, and more than 75% of hypertensive individuals are using antihypertensive medications. Therefore, it is important to examine blood pressure (BP) differences in populations that are using these medications with differing obesity status. AIM: We examined whether BP attained when using various antihypertensive medications varies amongst different body mass index (BMI) categories and whether antihypertensive medication use is associated with differences in other metabolic risk factors, independent of BMI. METHODS: Adults with hypertension from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2014 were used (n=15,285). Linear regression analyses were used to examine the main effects and interaction between antihypertensive use and BMI. RESULTS: In general, users of antihypertensive medications had lower BP than those not taking BP medications (NoBPMed) (P < 0.05), whereby in women, the differences in systolic BP between angiotensin-converting-enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) users and NoBPMed were greater in those with obesity (ACE inhibitors: −14 ± 1 mmHg; ARB: −16 ± 1 mmHg) compared to normal weight individuals (ACE inhibitors: −9 ± 1 mmHg; ARB: −11 ± 1 mmHg) (P < 0.05). Diastolic BP differences between women ARB users and NoBPMed were also greatest in obesity (−5 ± 1 mmHg) (P < 0.05) whilst there were no differences in normal weight individuals (−1 ± 1 mmHg) (P>0.05). Furthermore, glucose levels and waist circumference in women were higher in those using ACE inhibitors compared to diuretics (P < 0.05). CONCLUSION: ACE inhibitors and ARBs may be associated with more beneficial BP profiles in women with obesity, with no obesity-related BP differences for antihypertensive medication in men. However, there could be potential cardiometabolic effects for some antihypertensive medications that should be explored further. |
format | Online Article Text |
id | pubmed-6188586 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-61885862018-10-25 The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity Parikh, Jash S. Randhawa, Arshdeep K. Wharton, Sean Edgell, Heather Kuk, Jennifer L. J Obes Research Article INTRODUCTION: One in three US adults is living with obesity or hypertension, and more than 75% of hypertensive individuals are using antihypertensive medications. Therefore, it is important to examine blood pressure (BP) differences in populations that are using these medications with differing obesity status. AIM: We examined whether BP attained when using various antihypertensive medications varies amongst different body mass index (BMI) categories and whether antihypertensive medication use is associated with differences in other metabolic risk factors, independent of BMI. METHODS: Adults with hypertension from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2014 were used (n=15,285). Linear regression analyses were used to examine the main effects and interaction between antihypertensive use and BMI. RESULTS: In general, users of antihypertensive medications had lower BP than those not taking BP medications (NoBPMed) (P < 0.05), whereby in women, the differences in systolic BP between angiotensin-converting-enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) users and NoBPMed were greater in those with obesity (ACE inhibitors: −14 ± 1 mmHg; ARB: −16 ± 1 mmHg) compared to normal weight individuals (ACE inhibitors: −9 ± 1 mmHg; ARB: −11 ± 1 mmHg) (P < 0.05). Diastolic BP differences between women ARB users and NoBPMed were also greatest in obesity (−5 ± 1 mmHg) (P < 0.05) whilst there were no differences in normal weight individuals (−1 ± 1 mmHg) (P>0.05). Furthermore, glucose levels and waist circumference in women were higher in those using ACE inhibitors compared to diuretics (P < 0.05). CONCLUSION: ACE inhibitors and ARBs may be associated with more beneficial BP profiles in women with obesity, with no obesity-related BP differences for antihypertensive medication in men. However, there could be potential cardiometabolic effects for some antihypertensive medications that should be explored further. Hindawi 2018-10-01 /pmc/articles/PMC6188586/ /pubmed/30364090 http://dx.doi.org/10.1155/2018/4573258 Text en Copyright © 2018 Jash S. Parikh et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Parikh, Jash S. Randhawa, Arshdeep K. Wharton, Sean Edgell, Heather Kuk, Jennifer L. The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity |
title | The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity |
title_full | The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity |
title_fullStr | The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity |
title_full_unstemmed | The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity |
title_short | The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity |
title_sort | association between antihypertensive medication use and blood pressure is influenced by obesity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188586/ https://www.ncbi.nlm.nih.gov/pubmed/30364090 http://dx.doi.org/10.1155/2018/4573258 |
work_keys_str_mv | AT parikhjashs theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity AT randhawaarshdeepk theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity AT whartonsean theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity AT edgellheather theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity AT kukjenniferl theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity AT parikhjashs associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity AT randhawaarshdeepk associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity AT whartonsean associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity AT edgellheather associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity AT kukjenniferl associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity |